期刊文献+

肺癌组织、支气管肺泡灌洗液及痰标本中p16基因甲基化特异性PCR检测 被引量:4

Detection of aberrant methylation of p16 gene in lung tumor tissues,corresponding bronchoalveolar lavage fluid, and sputum by methylation-specific PCR
下载PDF
导出
摘要 目的 :探讨肺癌组织、支气管灌洗液及痰标本中p16基因甲基化特异性PCR检测的临床应用价值。方法 :选取 5 6例肺部疾病住院患者手术切除的病变肺组织和相应的支气管肺泡灌洗液 (BALF)及痰标本 ,其中 32例为肺癌 ,2 4例为良性肺部疾病。标本经一般处理 ,PCR扩增后 ,产物经电泳EB染色 ,紫外灯下观察。结果 :32例肺癌组织标本中 ,14例 (4 3.8% )在p16基因启动子区域呈现异常甲基化 ,其中 9例 (6 4 .3% )在相应的BALF中检出甲基化存在 ,5例 (35 .8% )在相应的痰标本中也检出甲基化存在。 2 4例良性肺部疾病 ,其中肺囊肿 10例 ,肺结核 14例 ,无论在手术切除标本还是BALF和痰标本中均未检出p16基因甲基化存在。结论 :MSP技术对肺癌患者BALF及痰标本中P16基因的异常甲基化检测具有高度特异性 ,是一项很有潜力的肺癌早期诊断新技术。 Aim:To explore the clinical value of methylation specific PCR (MSP) on the diagnosis of Lung cancer. Methods:Pathological tissues taken in operation, corresponding bronchoalveolar lavage fluid (BALF), and sputum were obtained from 56 hospitalized patients, among whom 32 were lung cancer, and 24 were benign lung diseases.After DNA extracting and PCR amplification, the PCR products were stained with EB and observed under ultraviolet lamp.Results:Among 32 lung cancer tissues,14(43.8%) were found abnormal methylation in promoter area of p16 gene,9(64.3%), in corresponding BALF, and 5(35.8%), in corresponding sputum. While among 24 cases of benign lung diseases no p16 gene methylation was found in pathological tissues taken in operation, corresponding BALF or sputum. Conclusion:MSP has specificity on the detection of abnormal methylation of P16 gene in BALF and sputum of patients with lung cancer. This suggests that MSP might be a promising technique for lung cancer early diagnosis
出处 《郑州大学学报(医学版)》 CAS 北大核心 2003年第5期734-736,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关资助项目 0 0 40 2 2 0 0 0
关键词 甲基化特异性PCR 肺肿瘤 诊断 组织 支气管灌洗液 痰标本 methylation specific PCR lung neoplasm diagnosis
  • 相关文献

参考文献7

  • 1Akao T, Kakehi Y,Itoh N, et al. A high prevalence of functional in activation by methylation modification of p16INK4A/CDKN2/MTS1 gene in primary urothelial cancera. Jpn J Cancer Res, 1997,88( 11 ) :1 078.
  • 2Herman JG, MerloA, MaoL, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res,1995,55(20) :4 525.
  • 3Herman JG ,Graff. JR, Myohanen. S, et al. Methyation-specifc PCR: A novel PCR assay for methylation status of CpG islands. Proc Nail Acad Sci USA, 1996,93 ( 18 ) :9 821.
  • 4Belinsky SA, Nikula, ILl, Palmisano, WA, et al. Aberrant methylation of P16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA,1998(20) :11 891.
  • 5Esteller M, Sanchez-Cespedes M, Rosell R, et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res, 1999,59 (1) :67.
  • 6Gonzalgo ML, Hayashida T,Bender CM, et al. The role of DNA methylation in expression of the p15/p16 locus in human bladder cancer cell lines. Cancer Res, 1998,58 ( 6 ) :1 245.
  • 7Zhang S J, Endo S, Ichikawa T, et al. Frequent deletion and 5CpG island methylation of the p16 gene in primary malignant lym-phoma of the brain. Cancer Res, 1998,58 (6) : 1 231.

同被引文献46

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部